The 340B Drug Discount Program

Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.

In this video, Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.

For more information about Dr. Fein's controversial op-ed on 340B pricing, see this Drug Channels post.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.